文献速递脊柱脊髓外科

混合内镜技术与微创Quadrant经椎间孔腰椎椎间融合术治疗单节段腰椎管狭窄症的对比研究

Percutaneous Uniportal Endoscopic Decompression Combined with Biportal Endoscopic Lumbar Interbody Fusion versus Minimally Invasive Quadrant Transforaminal Lumbar Interbody Fusion for Single-Level Lumbar Spinal Stenosis.
PubMed 文献 · World Neurosurg · 2025-05-12

本研究回顾性纳入68例单节段腰椎管狭窄症患者,比较经皮单通道内镜减压联合双通道内镜腰椎椎间融合术(A组,32例)与微创Quadrant经椎间孔腰椎椎间融合术(B组,36例)的临床结局。结果显示A组术后1个月腰背痛VAS、腿痛VAS和SF-36评分更优,术后3个月腰背痛VAS、ODI和SF-36评分更优,术后1、3、7天肌酸磷酸激酶水平更低(P<0.05);但椎间盘高度、矢状面Cobb角、腰椎前凸、融合率及并发症率组间无显著差异(P>0.1或P>0.05)。

要点

  • 混合内镜技术可减轻术后早期疼痛并促进功能恢复。
  • 混合内镜技术与微创Quadrant经椎间孔腰椎椎间融合术融合率相当。
  • 两组影像学参数(椎间盘高度、Cobb角、腰椎前凸)无显著差异。

核心结论

  • 混合内镜技术(经皮单通道内镜减压联合双通道内镜腰椎椎间融合术)与微创Quadrant经椎间孔腰椎椎间融合术治疗腰椎管狭窄症临床结局和融合率相当,但术后疼痛更轻、早期功能恢复更好。

研究设计与样本

  • 回顾性纳入2019年6月至2021年6月连续治疗的68例单节段腰椎管狭窄症患者,A组32例采用混合内镜技术,B组36例采用微创Quadrant经椎间孔腰椎椎间融合术,前瞻性收集围手术期数据。

主要发现

  • 术后1个月,A组腰背痛VAS、腿痛VAS和SF-36评分显著优于B组(P<0.05)。
  • 术后3个月,A组腰背痛VAS、ODI和SF-36评分显著优于B组(P<0.05)。
  • 术后1、3、7天,A组肌酸磷酸激酶水平显著低于B组(P<0.05)。
  • 术后1和12个月,椎间盘高度、矢状面Cobb角和腰椎前凸组间无显著差异(P>0.1)。
  • 两组融合率和手术并发症率无显著差异(P>0.05)。

临床怎么用

  • 对于单节段腰椎管狭窄症需行减压融合者,混合内镜技术可作为微创Quadrant经椎间孔腰椎椎间融合术的替代方案,以减轻术后早期疼痛并促进功能恢复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the clinical outcomes between group A (hybrid endoscopic technique: percutaneous uniportal endoscopic decompression combined with biportal endoscopic lumbar interbody fusion [LIF]) and group B (minimally invasive Quadrant transforaminal LIF) for lumbar spinal stenosis. METHODS: This study included 68 consecutive patients (group A: 32 patients; group B: 36 patients) retrospectively enrolled and treated between June 2019 and June 2021. Perioperative data were prospectively collected, including radiological outcomes (intervertebral disc height, sagittal Cobb angle, lumbar lordosis) and clinical outcomes (Oswestry Disability Index, visual analog scale [VAS], and Short Form 36 Health Survey [SF-36]). Paravertebral muscle injury was assessed by serum creatine phosphokinase levels. Additionally, fusion rate and perioperative complication rates were compared between the two groups. RESULTS: At 1 month postoperatively, group A demonstrated significantly better outcomes in VAS-Back, VAS-Leg, and SF-36 scores compared to group B (P < 0.05). At 3 months postoperatively, group A demonstrated significantly better outcomes in VAS-Back, Oswestry Disability Index, and SF-36 scores compared to group B (P < 0.05). Creatine phosphokinase levels in group A were significantly lower than those in group B at 1, 3, and 7 days postoperatively (P < 0.05). However, no significant intergroup differences were observed in intervertebral disc height, sagittal Cobb angle, and lumbar lordosis at 1 and 12 months postoperatively (P > 0.1). Additionally, fusion rates and surgical complication rates did not differ significantly between groups (P > 0.05). CONCLUSIONS: The hybrid endoscopic technique (percutaneous uniportal endoscopic decompression combined with biportal endoscopic LIF) demonstrates comparable clinical outcomes and fusion rates to minimally invasive Quadrant transforaminal LIF for lumbar spinal stenosis, while achieving reduced postoperative pain and improved early functional recovery.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ma ML, Ma ZJ, Wang BY, et al. Percutaneous Uniportal Endoscopic Decompression Combined with Biportal Endoscopic Lumbar Interbody Fusion versus Minimally Invasive Quadrant Transforaminal Lumbar Interbody Fusion for Single-Level Lumbar Spinal Stenosis. World Neurosurg. 2025. PMID: 40368092. doi:10.1016/j.wneu.2025.124070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。